Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering—A Cross-Sectional Analysis

DOI: 10.1634/theoncologist.2015-0397

Keywords: Orphan Drug Act, Orphan drug development, Rare diseases, Rare cancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text